Corporacion Sanitaria Parc Tauli

Sabadell 8916

0 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer, Crohn Disease, Crohn's Disease, Malignant Melanoma, Psoriatic Arthritis

Studies at this site

• Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies — Completed
• Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis — Completed
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease — Stopped early